Imidazole compounds used as phosphodiesterase VII inhibitors

US6884800B1 · kind B1 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Hans-Michael Eggenweiler · Darmstadt, DE
• Rochus Jonas · Darmstadt, DE
• Michael Wolf · Darmstadt, DE
• Michael Gassen · Munich, DE
• Thomas Welge · Alsbach, DE

Key dates

• Filing date: Oct 31, 2000
• Grant date: Apr 26, 2005
• Expiry date: Jul 10, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Imidazole compounds of the formula I in which